1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages by Kreutz, Marina et al.
1,25-Dihydroxyvitamin D3 Production and Vitamin D3 Receptor Expression 
Are Developmentally Regulated During Differentiation 
of Human Monocytes Into Macrophages 
By Marina Kreutz, Reinhard Andreesen, Stefan W. Krause, Andras Szabo, Eberhard Ritz, and Helmut Reichel 
It has been well established that human mononuclear 
phagocytes have the capacity to produce 1.25-dihydroxy- 
vitamin D3 [l ,25(OH),D3] and express thevitamin D recep- 
tor (VDR). However, la-hydroxylase activity and VDR re- 
ceptor expression during differentiation of monocytes 
(MO) into mature macrophages (MAC) have not been previ- 
ously examined. The in vitro maturation of blood MO can 
serve as a model for the in vivo transformation of immature 
blood MO into MAC. Here, when cultured in the presence 
of serum, MO undergo characteristic changes in morphol- 
ogy, antigenic phenotype, and functional activity consis- 
tent with their differentiation into MAC. We serially mea- 
sured l ,25(OH),D3 and 24,25-dihydroxyvitamin D3 [24, 
25(OH),D3] synthesis, specific ['Hl-l ,25(OH),D3 binding, 
and VDR mRNA levels during in vitro maturation of MO into 
MAC and correlated these functions with maturation-as- 
sociated changes in the phenotype (MAX.l and CD71) and 
secretory repertoire (interleukin-1 j3 [IL-1 81, neopterin) of 
the cells. MO showed only little conversion of 25-(OH)D3 
into 1 .25(OH),D3 (1.4 -C 0.4 pmol/106 cells/6 h, n = 5) 
that increased gradually during maturation into MAC at  
day 8 of culture (5.3 f 4.3 pmol/106 cells/6 h, n = 5). 
Interferon-y (IFN-y) increased baseline 1 ,25(OH),D3-syn- 
thesis approximately twofold during all phases of differen- 
tiation. The time course of increased 1 ,25(OH),D3-synthe- 
,2SDIHYDROXYVITAMIN D, [ 1 ,25(OH),D,] is a 1 principal regulator ofbone and mineral metabolism. In 
addition, this hormone has multiple effects on cells of the 
immune system.' 1 ,25(OH),D3 induces differentiation of 
several human cell lines of the monocytic l ir~eage~?~ and of 
normal human hematopoietic  cell^^^^ The hormone modu- 
lates various functions of monocytes (MO), such as antigen 
presentation, secretion of prostaglandin E,, and hydrogen 
per~xide,~*'*~ and influences the activity of T and B lympho- 
~ytes.~JO 
Most ofthe biologic actions of 1,25(OH),D3 are mediated 
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sis correlated with enhanced secretion of neopterin and 
expression of MAX.l and CD71. The addition of exoge- 
nous 1 ,25(OH),D3 did not influence constitutive 1,25- 
(OH)2D3 synthesis, but IFN-7-stimulated production was 
suppressed to baseline levels. Exogenous 1 ,25(OH),D3 
also stimulated 24.25(OH),D3 synthesis in freshly isolated 
MO (from 1.0 f 0.8 pmol/6 h to 5.6 2 0.9 pmol), 
whereas matured MAC showed no 24,25(OH),D3 synthe- 
sis. Furthermore, we examined the expression of the VDR 
during the differentiation process. VDR mRNA and protein 
were constitutively expressed in MO, whereas VDR was 
downregulated in mature MAC on both the mRNA and pro- 
tein levels. Homologous upregulation of VDR protein by 
1,25(OH)zD3 occurred in MO and, to a lesser degree, in 
MAC. In contrast, VDR mRNA concentrations were not in- 
fluenced by 1 ,25(OH)zD3. Taken together, our results 
show that MO into MAC differentiation in vitro is asso- 
ciated with (1) an enhanced capacity to synthesize 1.25- 
(OH),D3, (2) a loss of 24,25(OH),D3-synthesizing activity, 
and (3) a decrease in the expression of VDR mRNA and 
protein. Because l,25(OH),D3 was shown to induce differ- 
entiation of MO into MAC, our data suggest an autoregula- 
tory mechanism of MO/MAC generation by 1 ,25(OH),D3. 
Q 1993 by The American Society of  Hematology. 
through a hormone-receptor complex in a manner analo- 
gous with the mechanism of action for classical steroid hor- 
mones." Vitamin D3 receptors (VDR) are present in 
various normal and leukemic hematopoietic cells," eg, in 
MO and activated B and T lymphocytes. In contrast, the 
VDR is absent from normal resting B and T lymphocytes.'* 
The cDNA for the human 1,25(OH),D, receptor shows se- 
quence homology to the thyroid hormone receptor and 
other steroid hormone  receptor^.'^ 
Furthermore, evidence exists that cells of the mononu- 
clear phagocyte system (MPS) can metabolize 25(OH)D3 
into 1,25(OH),D3. Normal bone marrow and alveolar mac- 
rophages synthesize 1,25(OH),D3 after stimulation with in- 
terferon-y (IFN-y) or lipopolysaccharide (LPS).'5,16 In sar- 
coidosis, tuberculosis, and some cases of malignant 
lymphoma, the deregulated extrarenal 1 ,25(OH),D, produc- 
tion seems to play a crucial role in the generation of hyper- 
~alcemia.""~ Tissue macrophages (MAC) are thought to be 
the source of 1 ,25(OH),D3 in these diseases. Some evidence 
exists that 24,25-dihydroxyvitamin D, [24,25(OH),D3] can 
also be produced by MO/MAC." 
The terminal differentiation step from circulating blood 
MO into MAC is accompanied by characteristic changes in 
morphology, functional activity, and antigen expres- 
sion.20s2' This differentiation process can also be followed in 
vitro when blood MO are cultured in the presence of 
serum.22 Using this in vitro model of MAC maturation, we 
studied the developmental regulation of vitamin D metabo- 
lism and the regulation of VDR expression in human MO/ 
MAC. 
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MATERIALS AND METHODS 
Peripheral blood mononuclear 
cells (MNC) were obtained by leukapheresis of healthy donors, fol- 
lowed by density gradient centrifugation over Ficoll/Hypaque. MO 
were isolated from MNC by countercurrent elutriation (J6M-E 
Beckmann centrifuge; Beckmann, Munich, Germany) using a 
large-volume chamber (50 mL), a JE-5 rotor at 2,500 rpm, and a 
flow rate of I I O  mL/min in Hanks' Balanced Salt Solution supple- 
mented with 290 human albumin. Elutriated MO were more than 
90% pure as determined by morphology and antigenic phenotype. 
Purified MO were cultured on Teflon foils (Biofolie 25; Heraeus, 
Hanau, Germany) for up to 14 days at a cell density of IO6 cells/mL 
in RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 5 
x 1 0-5 mol/L mercaptoethanol, polyvitamins, antibiotics, pyru- 
vate, nonessential amino acids, and 5% pooled human AB-group 
serum. After the indicated time period, cells were harvested, washed 
twice, counted by trypan blue exclusion, and cultivated for another 
24 hours in 6-well microtiterplates or petridishes (both from Fal- 
con/Becton Dickinson, Heidelberg, Germany) as described below. 
MO or MO-derived MAC were seeded into 
6-well microtiterplates at lo6 cells/well/mL in RPMI 1640 without 
serum. Cells were grown in the presence of 500 U/mL IFN-y (Bio- 
feron, Laupheim, Germany), lo-' mol/L 1 ,25(OH),D, (kindly pro- 
vided by Hoffmann-La Roche, Basel, Switzerland), IFN-y, and 
1,25(OH),D, or in vehicle for 18 hours. Then, 50 nmol/L 25- 
(26,27-methyl-'H)(OH)D3 was added (165 Ci/mmol; Amersham, 
Braunschweig, Germany) for another 6 hours. In experiments per- 
formed in the presence of 1,25(OH),D3, every well was washed 3 
times with RPMI 1640 before adding 25-('H)(OH)D,. Control ex- 
periments were performed using only medium and 25-(,H)(OH)D, 
without cells. 1 a-Hydroxylase activity was not detected in control 
incubations. The reaction was terminated by adding 1 mL metha- 
nol, and cells were detached from the plastic surface with a cell 
scraper. Cells and supernatants were harvested and stored at -20°C 
until use. All incubations were performed in duplicate or triplicate. 
MO or MO-derived 
MAC were seeded at IO6 cells/2 mL into 6-well microtiterplates in 
RPMI 1640 with 2% pooled human AB-group serum. Cells were 
stimulated with 100 ng/mL LPS Salmonella abortus equi (kindly 
provided by Chris Galanos; Max-Planck Institut fur Immunbiolo- 
gie, Freiburg, Germany) or IFN-y (500 U/mL) for 24 hours. Con- 
trols were performed without stimulus. Supernatants were har- 
vested, filtered through 0.22 pm filters, and stored at -20°C. 
Detection of interleukin-lp (IL-Io) and neopterin. IL-lo was 
measured by commercially available sandwich enzyme-linked im- 
munosorbent assay (Biochrom, Laupheim, Germany) and neo- 
pterin by radioimmunoassay (IBL, Hamburg, Germany). 
Either MO or MO-de- 
rived MAC obtained after a culture period of 7 days in Teflon bags 
were seeded into plastic dishes at a density of lo6 cells/mL and 
cultured in the presence or absence of 1 ,25(OH)2D, (IO-' mol/L) or 
IFN-y (200 U/mL), respectively. After 4 hours the supernatant was 
discarded, cells were lysed directly in the dishes with guanidium- 
thyocyanate solution and RNA extraction was performed accord- 
ing to Chomzynski and Sacchi.', Six micrograms of total RNA was 
run in 1% agarose-formaldehyde gels and transferred to nylon 
membranes (Nytran, Schleicher and Schull, Dassel, Germany). 
VDR mRNA was detected by hybridization of the membranes 
with a full-length human VDR cDNA probe (kindly provided by 
W. Pike, Houston, TX)I4 labeled with (32P)d-cytidine triphosphate 
(3,000 Ci/mmol; Amersham, Buckinghamshire, UK) by the ran- 
dom-prime method with a commercially available kit (Amersham). 
As a control, glycerolaldehyde-3-phosphate-dehydrogenase (GAP- 
DH) mRNA was detected by hybridization with an oligonucleotide 
Cell separation and culture. 
Hydroxylase assay. 
Production of MO/M.4C supernatants. 
RNA-extraction and Northern analysis. 
probe complementary to bp I 101 through 1187 of the published 
sequence.z4 This probe was labeled with T4 polynucleotide kinase 
(Boehringer Mannheim, Mannheim, Germany) and ~('~P)adeno- 
sine triphosphate (5,000 Ci/mmol; Amersham). Hybridization 
conditions were 500 mmol/L sodiumphosphate pH 7.2,7% sodium 
dodecyl sulfate (SDS), 1 mmol/L EDTA, 150 pg/mL tRNA 
(adapted from Church and Gilbertz5) at 65OC overnight. Washing 
conditions were 3 X 30 minutes 0.1X SSC, 1% SDS at 52°C. The 
different probes were hybridized to the same membranes after strip- 
ping of the previous probes at 0. I X SSC, 1% SDS, 70°C for 3 hours. 
X-ray films (Kodak XAR; Eastman Kcdak Company, Roches- 
ter, New York) were exposed to the filters for 10 days (VDR) or 
overnight (GAP-DH) with an intensifying screen. The intensity of 
the radioactive signals was determined by laser densitometry (Phar- 
macia, Uppsala, Sweden) of the X-ray films. 
Phenotype analysis. MAC were attached to alcian-blue-coated 
slides and prefixed with 0.05% glutaraldehyde on ice. They were 
incubated with the following mouse monoclonal antibodies 
(MoAb): anti-gp65 (MAX. I ,  from our laboratory) and anti-CD7 1 
(OKT9, Ortho Diagnostics, Neckargmund, Germany). A peroxi- 
dase-anti-peroxidase (PAP) technique was applied followed by 
postfixation with O S O , . ~ ~  
Analysis of 25(0H)D3 metabolism. Cells and medium were 
combined for analysis of 25(OH)D, metabolism. Lipids were ex- 
tracted by the procedure of Bligh and Dyer." After evaporation of 
the chloroform under a stream of nitrogen, the samples were taken 
up in the appropriate solvent, and the radioactive metabolites were 
separated by high performance liquid chromatography (HPLC) on 
a liquid-chromatograph (Waters, Frankfurt, Germany). Radioac- 
tive 25(OH)D,-metabolite peaks were localized by measuring the 
tritium content of successive I-minute fractions by liquid scintilla- 
tion measurements. The tritium peaks were compared with the elu- 
tion positions of chemically synthesized radioinert vitamin D, me- 
tabolites that were included in each HPLC run to serve as internal 
standards. Their migration was determined by UV absorbance mea- 
surements at 254 nm. Conversion of 25(OH)D, was analyzed with a 
Radial PAK pPorasil cartridge (Waters) that was eluted over 22 
minutes with a 4% to 60% nonlinear gradient of isopropanol in 
n-hexane (flow-rate 2 mL/min). On this system, 25(OH)D3 eluted 
after 5 minutes, 24,25-dihydroxyvitamin D, (24,25(OH),D3) after 
12 minutes, and 1,25(OH),D, after 17 minutes. One replicate of 
each incubation was consecutively chromatographed on hexane- 
based straight-phase HPLC and on reverse-phase HPLC. Reverse- 
phase HPLC was performed with a pBondapak C 18 steel column 
(Waters), 0.39 X 30 cm, eluted with water/methanol (1535, vol/ 
vol), at a flow rate of 1 mL/min. Thirty-two fractions were collected 
from this system. In all experiments, the elution position of the 
metabolite from MO/MAC matched the elution position of chemi- 
cally synthesized 1,25(OH),D, on the two HPLC systems. 
1,25(OH)zD, 
binding capacity was determined by a modification of a previously 
described method.2' Briefly, cultured cells were scraped in ice-cold 
TEDMo (10 mmol/L Tris HCl, 1.5 mmol/L EDTA, 1 mmol/L 
DTT, I O  mmol/L sodium molybdate, pH 7.4,4"C)-phenylmethyl- 
sulphonyl flouride (PMSF)/aprotinin (PMSF and aprotinin both 
from Serva, Heidelberg, Germany) buffer and were then homoge- 
nized in TEDMo-PMSF/aprotinin buffer (40% wt/vol) with a Poly- 
tron homogenizer. The homogenates were centrifuged (5,OOOg for 
I O  minutes) to yield the cytosol fraction and the nuclear pellet. A 
crude chromatin fraction was prepared resuspending the pellet two 
times in the above buffer with 0.5% Triton X-100 (Sigma, 
Munchen, Germany) followed by centrifugation (10,oOOg for 10 
minutes). The pellet was washed with TEDMo buffer without Tri- 
ton X-100 followed by centrifugation (10,000gfor 10 minutes). The 
resulting crude chromatin pellet was resuspended in TEDMo- 
PMSF/aprotinin buffer, extensively vortexed, and briefly ultrasoni- 
Measurement of 1,25(OH),D3 binding capacity. 
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cated for further analysis. Aliquots of the chromatin fraction and 
the cytosol fraction were removed for protein measurement. Ali- 
quots of the chromatin and the cytosol preparations, respectively, 
were incubated with 3 nmol/L ['H]-1,25(OH),D3 for total binding 
and 200X excess unlabeled hormone for unspecific binding. The 
assay tubes were vortexed and incubated for 18 hours at 4°C. 
Bound activity was separated from free activity by batchwise treat- 
ment with hydroxyapatite (Sigma) as described previou~ly.~~ Be- 
cause of limited availability of cells, Scatchard saturation analysis 
could not be performed. Data are presented as combined-specific 
[3H]- 1 ,25(OH),D3 binding capacity from chromatin and cytosol 
fractions. 
RESULTS 
25(0H)D, metabolism at various stages of differentia- 
tion. Freshly isolated MO produced small amounts of 
[3H]-1,25(OH)2D3 (1.4 k 0.4 pmol/106 cells/6 h, n = 5). 
During cultivation of cells, 1 ,25(OH),D, production in- 
creased gradually and typically reached a peak between days 
6 and 8 of the culture period. Taken together, l,25(OH)2D3 
production on day 4 (2.7 f 1.3, n = 4) and day 8 (5.3 ? 4.3, 
n = 5 )  by unstimulated cells was significantly (P c .05) 
higher than hormone production by freshly isolated MO. 
Average I ,25(OH)2D, production by unstimulated MAC 
on day I4 ( I  .2 & 1.1, n = 5) was comparable to that on day 
0. An HPLC chromatogram of [3H]-25(OH)D, metabolism 
by day 8 MAC is shown in Fig I .  Further monitoring of 
1 a-hydroxylase activity up to day 14 showed a decrease in 
1 ,25(OH),D, synthesis with increasing culture time. A time 
course of 1,25(OH),D3 production during differentiation of 
MO into MAC is shown in Fig 2. The similarity between 
la-hydroxylase activity (Fig 2A) and the time course of se- 
cretion of neoptenn (Fig 2B, a marker of mature MAC) is 
evident. IL-la, a cytokine that is predominantly secreted by 
freshly isolated MO, has an inverse correlation to the I a-hy- 
droxylase activity (Fig 2B). There is also a relationship be- 
tween the increase of maturation-associated antigens 
(MAX. I and transfemn receptor/CD7 1) and la-hydroxy- 
lase activity (Fig 2C). Activation of MO/MAC by IFN-y 
stimulated 1,25(OH),D, production at all time points tested 
except in freshly isolated MO (Fig 2A). On day 8, there was 
an approximately twofold increase in 1 ,25(OH),D, synthe- 
sis. The time course of 1,25(OH),D3 production by IFN-y- 
treated MO/MAC closely resembled the time course in un- 
treated cells. An increase until day 6 through 8 was followed 
by a gradual decrease until day 14 (Fig 2A). IFN-y signifi- 
cantly (P < .05) stimulated 1,25(OH),D3 synthesis on day 4 
(6.4 k 1.4, n = 4) and on day 8 (10.4 f 7.3, n = 4). On day 
14, there was no longer a statistically significant stimulation 
of I ,25(OH)2D, synthesis by IFN-y. 
The effect of exogenous 1,25(OH),D, on the regulation of 
the 1 a-hydroxylase activity was assessed in further experi- 
ments by incubating cells for 18 hours in the presence of 10 
nmol/L 1,25(OH),D,. As summarized in Fig 3, 1,25- 
(OH),D, did not influence la-hydroxylase activity in un- 
treated cells at all stages of differentiation (days 0,4,  8, and 
14). In contrast, IFN-y-activated MAC were sensitive to 
1 ,25(OH),D3 regulation. The IFN-y-stimulated increment 
in hormone synthesis was blocked by exogenous 1,25- 
Constitutive 24,25(OH),D3 production vaned somewhat 
between cell preparations ( I  f 0.8 pmol/106 cells/6 h) and 
was found in 3 of 5 experiments. The baseline 24-hydroxy- 
lase activity in MO decreased upon maturation of cells and 
ceased until day 4. Because renal 24,25(OH),D, production 
is stimulated by I ,25(OH),D3, we looked for a similar behav- 
ior in MO/MAC. The conversion of 25(OH)D3 into 
24,25(OH),D, during differentiation of MO into MAC after 
incubation with 1 ,25(OH),D3 or 1,25(OH)2D, plus IFN-y is 
shown in Fig 4. A pronounced stimulation of 24,25(OH),D3 
synthesis after exposure to 1,25(OH)@3 occurred on day 0 
(5.6 f 0.9 pmol/106 cells/6 h, n = 2). On day 4, inducible 
24-hydroxylase activity decreased markedly; on day 8, the 
(OH)zD, (Fig 3). 
elution time 
Fig 1.  HPLC profile of 13H]- 
25(OH)D3 metabolism by MO- 
derived MAC, cultured for 8 
days. Cells were incubated for 
6 hours with 50 nmol/L 
25(OH)(3H)D3. Lipid extracts of 
cells and media were analyzed 
by HPLC using a Radial PAK 
pPorasil cartridge eluted over 
22  minutes with a 5% to 60% 
gradient of isopropanol in n- 
hexane (flow rate, 2 mL/min). 
Tritium contents of consecutive 
2 mL fractions are shown. The 
arrows indicate the elution po- 
sitionof authenticvitamin Dme- 
tabolites. 
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Fig 2. (A) 1 ,25(0H),D3 production by human MO and MO-de- 
rived MAC. Cells were cultured for the indicated time period on 
Teflon foils. MO/MAC were harvested and plated in 6-well plates 
at a cell density of 10” cells/well/mL. MO/MAC stimulated with 
500 U/mL IFN-y or unstimulated were cultured for 18 hours and 
then pulsed with 25-(26,27-methyl-’H)(0H)D3 for 6 hours. The ex- 
periment was performed in triplicate incubations. (B) Secretion of 
neopterin and IL-la during the differentiation of MO/MAC. The 
same cells used for analysis of 1 ,25(OH),D3 synthesis were plated 
in 6-well plates at a cell density of 1 0”/2 mL and stimulated with 
500 U/mL IFN-y (for neopterin analysis) or 100 ng/mL LPS (for IL- 
16 analysis) for 24 hours. (C) Expression of MAX.l and CD71 dur- 
ing the differentiation of MO/MAC. The cells were harvested at the 
indicated time points and surface antigens analyzed by immuno- 
peroxidase staining. 
24,25(OH),D3 hydroxylase could no longer be stimulated 
by 1,25(OH),D3 (Fig 4). IFN-y had no clear effect on the 
24-hydroxylase. Baseline 24,25(0H),D3 production by MO 
on day 0 was similar in the absence or presence of IFN-y. AS 
compared with 1,25(OH),D3 alone, the addition of 
1,25(OH),D3 plus IFN-y resulted in a slight reduction of 
24,25(OH),D3 synthesis (Fig 4). 
MAC between days 4 and 8 inconsistently produced 
25(OH)(’H)D3 metabolites that were more polar than 
I ,25(OH),D3 (Fig I). The synthesis ofthe polar material was 
not related to IFN-y exposure. This material was not further 
characterized. 
The 
expression of VDR mRNA in MO and MO-derived MAC 
was studied in further experiments. Total RNA was isolated 
either on day 0 or day 7. Figure 5 shows the Northern blots 
for the VDR compared with the expression of GAP-DH in 
MO/MAC. MO show a strong, constitutive expression of 
the VDR mRNA, which is markedly downregulated in MO- 
derived MAC on day 7. Exposure to I ,25(OH),D3 or IFN-y 
resulted in a slight reduction of VDR mRNA in both MO 
and MAC (Fig 5). These changes were less pronounced in 
two other experiments and were not statistically significant. 
VDR expression a! various stages qfdiferenliation. 
VDR protein concentrations, as measured by [’HI- 
1 ,25(OH),D3 binding capacity, are summarized in Table 1. 
In parallel with VDR mRNA concentrations, VDR protein 
concentrations in MO were approximately twofold higher 
than in MAC. In contrast to VDR mRNA data, incubation 
with 1 ,25(OH),D3 caused significant upregulation of [’HI- 
1,25(OH),D3 binding in either cell type. However, the in- 
crease of VDR protein was more pronounced in MO. 
DISCUSSION 
The terminal differentiation process of MO into mature 
MAC is a crucial event in the development of fully compe- 
tent mononuclear phagocytes. A similar process occurs in 
vitro when blood MO are cultured in the presence of 
serum.z2 MO-derived MAC show a typical MAC morphol- 
ogy and functional activity in terms of high TNF-(U and 
neopterin release and low secretion of IL- I6 and IL-6.30’2 In 
addition the expression of specific maturation-associated 
antigens can be detected during in vitro differentia- 
ti~n.~’.’’.’~ The results ofthis study show that the capacity of 
MO/MAC to synthesize 1,25(OH),D, and to express the 
VDR is regulated in a reciprocal fashion during differentia- 
tion of cells. 
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1,25(OH)2D3 (pmol/well) 
:I 4 * unrtlmulatrd a 1,26(OH)2D3 n IFN-gamma 
0 4 8 
Days in Culture 
Although freshly isolated MO produced relatively low 
amounts of 1 ,25(OH),D3, basal I-a-hydroxylase activity in- 
creased rapidly during the differentiation process of MO 
into MAC. These changes were accompanied by a charac- 
teristic increase of maturation-associated antigens (MAX. 1 
and CD7 1) and release of neopterin, whereas IL-la secre- 
tion decreased. These results suggest that the capacity to 
synthesize 1,25(OH),D, is acquired by MO during the dif- 
ferentiation process into MAC, whereas less mature cells 
have no or little 1 -a-hydroxylase activity. Accordingly, im- 
mature human cell lines of the monocytic lineage (HL-60 
and U937) showed no 1 ,25(OH)2D3 synthesis,,' whereas 
mature pulmonary alveolar MAC (PAM) and bone 
marrow-derived MAC (BMM) had the ability to convert 
25(OH)D, into 1,25(OH),D, .I5 In our system, 1,25(0H),D3 
production decreased after 8 to 10 days of culture. The rea- 
son for this is not apparent, but similar results were found 
with PAM and BMM.I5 
7 
6 
6 
4 
Fig 4. 24,25(OH),D3-synthesis by MO/MAC. 3 
Cells were cultivated for the indicated time period, 
harvested, and plated in 6-well plates. MO/MAC 
were stimulated with lo-' mol/L 1.25(OH),D3. 
500 U/mL IFN--,, 1 ,25(OH),D3 plus IFN-7, or with- 
out any stimulus for 18 hours. Then cells were 
washed and pulsed for another 6 hours with 25- 
('H)(OH)D,. Results represent the means of two 
experiments, each performed in duplicate incuba- 
tions. (*P < .05 v unstimulated, #P < .05 v IFN- 
7) .  
i 
14 
Fig 3. Effectof 1,25(OH)2D3(10-8mol/L)on hy- 
droxylase-activity in MO/MAC. Cells were cultured 
for the indicated time period, harvested, and plated 
in 6-well plates at a cell density of 10' cells/well/ 
mL. MOIMAC were stimulated with 500 U/mL 
IFN--,, lo- '  mol/L 1,25(OH),D3, or IFN--, plus 
1 ,25(OH),D, for 18 hours. Then cells were washed 
3 times and pulsed for another 6 hours with 25- 
(3H)(OH)D3. Results represent the means of two 
experiments, each performed in duplicate incuba- 
tions. (*P < .05 v unstimulated, #P < .05 v IFN- 
7) .  
IF"-./ augmented 1 ,25(OH),D, synthesis by MO/MAC 
at all time points tested. These results showed that, in addi- 
tion to the stage of differentiation, the degree of activation is 
a second determinant of 1 a-hydroxylase activity. The re- 
sponsiveness of 1 a-hydroxylase to IFN-./ did not vary in an 
apparent fashion during differentiation. 
In the kidney, there is a feedback regulation of 
1 ,25(OH),D3 production by exogenous or endogenous 
1 ,25(OH),D,. Corresponding results with cultured renal epi- 
thelial cells showed a downregulation of 1,25(OH),D, syn- 
thesis and an increase in 24,25(OH),D3 ~ynthesis.,~ There- 
fore, we examined the action of exogenous 1 ,25(OH),D3 on 
1-a-hydroxylase activity in MO/MAC. In contrast to renal 
cells, basal 1,25(OH),D, production was not altered by 
1,25(OH),D, in MO/MAC. Previous studies with normal 
and sarcoid PAM and BMMI's~~ also showed little or no 
inhibition of hormone synthesis by exogenous 1,25(OH),- 
D,. Dusso et ai3' recently showed that 1,25(OH),D3 produc- 
n = unrtlmulatod 
a *IFN 
a 1,26(OH)2DS 
IFN 1,26(OH)2D3 
0 4 8 14 
Days in Culture 
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- 3  +VD3 
- 4  MO 
- 5  + IFN 
Fig 5. Expression of VDR 
mRNA in human M O  (day 0) 
and MAC (day 8). Freshly iso- 
lated M O  or MO-derived MAC 
were seeded into plastic dishes 
and cultured in the presence of 
500 U/mL IFN-y, lo-* mol/L 
1 ,25(OH)2D3, or without any 
stimulus. After 4 hours, RNA 
was extracted and Northern 
analysis performed according 
to Materials and Methods. The 
VDRIGAP-DH ratios obtained 
by densitometric screening are 
shown next to the respective 
lanes. 289 
hVD3R 
i 
I 
0.22 
1.51 
0.92 
tion was inhibited by exogenous 1,25(OH),D3. The reason 
for the discrepancy between their findings and our study is 
not clear. 
In contrast to the constitutive 1,25(OH),D3 synthesis, the 
IFN-7 augmented production of I ,25(OH),D3 in MO/ 
MAC was suppressed to baseline levels by exogenous 
1 ,25(OH),D3. Whereas 24,25(OH),D3 synthesis could 
never be induced in MAC, 24,25(OH),D3 production was 
regularly detected in freshly isolated blood MO upon the 
addition of 1 ,25(OH),D3. Obviously, the capacity to synthe- 
size 24,25(OH),D3 was rapidly lost during the differentia- 
tion of MO into MAC. Accordingly, others have found 
24,25(OH),D3 synthesis after exposure to I ,25(OH),D3 in 
freshly isolated M03’ and in the monocytic cell line HL- 
60,35 whereas mature MAC (PAM, BMM) had no 24-hy- 
droxylase activity after short-term exposure to 1 ,25(OH),D3.” 
In contrast, Hayes et a139 reported spontaneous 
24,25(OH),D3 synthesis in PAM of a patient with rhabdo- 
myosarcoma, but the MAC of this patient might not have 
been normal. 
Most of the actions of 1,25(OH),D3 are thought to be 
mediated through intracellular receptors. Therefore, we 
looked for the expression of VDR during the differentiation 
of MO into MAC. MO showed a strong constitutive expres- 
sion of VDR mRNA and VDR protein, whereas VDR was 
down-regulated in mature MAC on both levels. Homolo- 
gous upregulation of VDR-protein, which had been shown 
Table 1. [’HI-1 ,25(OH)2D3 Binding Capacity During In Vitro 
Differentiation of MO to MAC 
GAP-DH 
1305 
hVD,R/GAP-DH 
- 1  MAC ? - 2  + IFN 
- 6  +VD3 1.23 
I 
189 
[’HI-1 ,25(OH),D3 Binding 
(fmol/mg protein) 
MO 336 2 57’ 
MO + 1,25(OH),D3 5 5 4 ?  115t 
MO + IFN-y 270 
MAC 1 7 0 2 3 2  
MAC + 1,25(OH)$j 240 2 59$ 
MAC + IFN-y 154 
Data are the means 2 SEM from three experiments (except IFN-7 
P <  .03 vMAC. 
t P < .03 vMO. * P < .05 v MAC (Mann-Whitney U-test for paired data). 
treatment, for which data are from one experiment). 
for various cell types,4043 also occurred in cultured MO and 
MAC. However, in quantitative terms, responsiveness to 
1,25(OH),D3 was lower in MAC than in MO. Homologous 
upregulation of VDR is likely to have occurred on a post- 
transcriptional level, because VDR mRNA concentrations 
were not affected by 1 ,25(OH),D3. These data are in agree- 
ment with previous data on HL-60 promyelocytic cells and 
other hematopoietic cells types.”*42 Taken together, VDR 
was downregulated during differentiation of MO to MAC. 
Responsiveness to 1,25(OH),D3 was, to some degree, pre- 
served in matured MAC, because VDR protein was upregu- 
lated after incubation with I .25(OH)2D3. Because 
25(OH)D324-hydroxylase activity could no longer be in- 
duced in MAC, differential behavior of 1 ,25(OH),D3-re- 
sponsive genes with respect to exposure of 1,25(OH),D3 
must be discussed. 
In summary, we show that the capacity of MO/MAC to 
convert 25(OH)D3 to its metabolites I ,25(OH),D3 and 
24,25(OH),D3 and the expression of VDR are dependent on 
the stage of maturation of the cells. Whereas 24,25(OH),D3 
is mostly produced by freshly isolated MO, which lose this 
capacity upon differentiation into MAC, the secretion of 
1 ,25(OH),D3 is upregulated during the maturation process 
of MO into MAC. These changes are accompanied by a 
reduction in the constitutive expression of the VDR. There- 
fore, we conclude that MO (and more immature cells ofthe 
monocytic lineage) are the main target for 1,25(OH),D3,4.’ 
because these cells strongly express the VDR. During the 
differentiation into MAC, there is a downregulation of the 
VDR, but these cells are potent 1,25(OH),D3 producers. 
Taken together, our results suggest an autoregulatory mech- 
anism in which MAC recruit cells of their own lineage 
from the pool of circulating blood MO through the pro- 
duction of 1 ,25(OH),D3. The role of 24,25(OH),D3 in 
this system needs to be clarified through further investiga- 
tion. 
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